Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study

Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study

Abstract Background Unfractionated heparin sodium and nafamostat mesylate have long been used as anticoagulants in continuous kidney replacement therapy (CKRT) where citrate is unavailable. This study aimed to determine whether heparin or nafamostat mesylate used during CKRT was associated with a lo...

Full description

Bibliographic Details
Main Authors: Shinya Kameda, Tomoko Fujii, Junpei Ikeda, Akira Kageyama, Toshishige Takagi, Naoki Miyayama, Kengo Asano, Arata Endo, Shoichi Uezono
Format: Article
Language:English
Published: BMC 2023-01-01
Series:BMC Nephrology
Subjects:
Acute kidney injury
Continuous kidney replacement therapy
Nafamostat mesylate
Unfractionated heparin sodium
Filter life
Anticoagulant
Online Access:https://doi.org/10.1186/s12882-023-03060-1

Internet

https://doi.org/10.1186/s12882-023-03060-1

Similar Items